ExpreS2ion Biotech

These events represent important opportunities to showcase ExpreS2ion’s innovative technology platform and exciting development pipeline to scientific and investment audiences. More details, including event registration information, are available on the Company’s website and via the links below. To arrange a meeting at either event, please contact us at info@expreS2ionbio.com.

13-14 May 2025 | Bio€quity Europe
Bruges, Belgium
ExpreS2ion will be participating in BioEquity Europe 2025, a leading investor conference for the European biopharma sector, taking place in Bruges on May 13-14, 2025. CEO Bent Frandsen will present ExpreS2ion’s innovative pipeline and growth strategy in the Vaccine Platforms track on May 13th at 16:00, engaging with prominent European investors and pharmaceutical companies. Join us to learn more about ExpreS2ion’s advancements and strategic initiatives. For further event details, visit BioEquity Europe.

15 May 2025 | Presentation of Interim Results for Q1 2025
Webinar
CEO Bent Frandsen will present the Q1 2025 report at a virtual live event for investors on May 15th at 13.00 CET, hosted by H.C. Andersen Capital. Registration is already open, and participants can submit questions in advance. The event is free for everyone to join via this link: https://www.inderes.dk/videos/expres2ion-biotechnologies-presentation-of-q1-2025

Certified Adviser
Svensk Kapitalmarknadsgranskning AB